MedPath

Clinical study of Modified Xiaochengqi Decoction in perioperative period of biliary tract surgery: A Randomized Controlled Trial

Not Applicable
Conditions
Biliary tract
Registration Number
ITMCTR2000003321
Lead Sponsor
Affiliated Hospital of Binzhou Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Temporary halt
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Patients with biliary tract diseases with surgical indications in hepatobiliary surgery, Affiliated Hospital of Binzhou Medical College;
2. Patients with elective surgery;
3. Patients without serious cardiopulmonary complications, the American Society of anesthesiologists grade I or II;
4. Patients with primary biliary tract operation;
5. All patients signed informed consent.

Exclusion Criteria

1. Patients with acute inflammation, fever and other diseases that have a serious impact on the stress response and inflammatory response of the body, and patients with immune diseases, metabolic diseases and drug use history of using immunosuppressants, hormones and other drugs that affect the immune system of the body;
2. Patients with severe cardiopulmonary complications, ASA grade III or above;
3. Emergency operation patients;
4. The patients who had bile duct operation again.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Indicators of acute inflammatory stress;Clinical indicators;Immune Indicators;Adverse reactions of taking traditional Chinese medicine;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath